Position in DXCM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$536,981
+$29,746 QoQ
Shares Held
7,973
-1.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#567
of 971 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GROUPAMA ASSET MANAGMENT holds $82,555,674 across 7 Medical Devices names. DXCM ranks #6 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
1,571,750 | $67,082,290 | |
| 2 | ABT |
Abbott Laboratories
|
85,053 | $7,717,709 | |
| 3 | MDT |
Medtronic plc
|
53,429 | $4,179,750 | |
| 4 | EW |
Edwards Lifesciences Corp
|
21,950 | $1,985,597 | |
| 5 | PODD |
Insulet Corp
|
3,918 | $596,515 | |
| 6 | DXCM |
Dexcom Inc
This page
|
7,973 | $536,981 | |
| 7 | SYK |
Stryker Corp
|
1,451 | $456,832 |
All Filings in DXCM
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $536,981 | 7,973 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $507,235 | 8,077 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $611,732 | 9,217 | Shares | Sole | 2026-02-27 | |
| 2025-09-30 | $3,653,705 | 4,000,000 | Principal | Sole | 2025-12-01 | |
| 2025-09-30 | $676,802 | 10,058 | Shares | Sole | 2025-12-01 | |
| 2025-06-30 | $3,747,555 | 4,000,000 | Principal | Sole | 2025-08-13 | |
| 2025-06-30 | $1,441,419 | 16,513 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $346,571 | 5,075 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $599,373 | 7,707 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,114,930 | 2,800,000 | Principal | Sole | 2024-11-15 | |
| 2024-09-30 | $3,456,314 | 51,556 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $2,290,049 | 20,198 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,891,340 | 20,846 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,897,129 | 23,347 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||